Fundraising Fox

Polaris Partners2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Tectonic TherapeuticNASDAQ: TECXApr 2021SEC filingmedium confidence

BiotechWatertown, US

Timothy Springer(Director)Andrew Kruse(Director)Timothy A. Springer(Director)Alise Reicin(Executive Officer, Director)Daniel Lochner(Executive Officer)Marc Schwabish(Executive Officer)

Board seatTerry McGuire· per SEC Form D · $80.1M raise · filed Apr 2021

Co-investorsAlly Bridge GroupClarusEcoR1 CapitalSoleus CapitalVida Ventures

Blue Rabbit VenturesMar 2021SEC filingmedium confidence

BiotechPortland, US

Benjamin J. Shaw(Executive Officer, Director)

BoardEdward L. Cahill(Director)

Board seatTerrance G. McGuire· per SEC Form D · $14.5M raise · filed Apr 2021

Glympse Bioglympsebio.comDec 2021SEC filingmedium confidence

BiotechCambridge, US

Gabriel Kwong(Executive Officer)Sirshendu Roopom Banerjee(Executive Officer)

BoardTheresia Guow(Director)Stan Lapidus(Director)

Board seatAmy Schulman· per SEC Form D · $18M raise · filed Dec 2021

Co-investorsGreatPoint VenturesAcrew CapitalAspect VenturesCatalio Capital ManagementDns CapitalNew Leaf Venture Partners+2 more

Jnana Therapeutics Inc.Aug 2021SEC filingmedium confidence

Boston, US

Board seatTerrance G. McGuire· per SEC Form D · $50M raise · filed Aug 2021

Co-investorsVersant Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.